POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 Genetic Test sale cost 4400 AED
ACTA2 Gene Multisystemic Smooth Muscle Dysfunction Syndrome Genetic Test sale cost 4400 AED ACTA2 Gene Multisystemic Smooth Muscle Dysfunction Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CHRNB1 Gene Myasthenic Syndrome Congenital Genetic Test sale cost 4400 AED CHRNB1 Gene Myasthenic Syndrome Congenital Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the POMGNT2 gene. This gene plays a crucial role in the proper development and functioning of muscles, the brain, and eyes. Mutations in POMGNT2 can lead to a rare form of muscular dystrophy-dystroglycanopathy, which is characterized by congenital muscular dystrophy coupled with brain and eye anomalies, classified as Type A8.

This genetic test is essential for the early detection and diagnosis of this condition, enabling healthcare providers to develop a tailored management and treatment plan for affected individuals. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for any genetic abnormalities associated with the condition.

The cost of the POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 genetic test at DNA Labs UAE is 4400 AED. Given the complexity and specificity of this test, it represents a crucial investment in the health and well-being of individuals at risk of or suspected to have this rare disorder. Early diagnosis through genetic testing can significantly impact the quality of life, allowing for timely interventions and support for those affected and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 Genetic Test

Genetic testing plays a crucial role in diagnosing and managing various genetic disorders. One such disorder is POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 (MDDGA8). This genetic disorder is characterized by muscle weakness and wasting, brain abnormalities, and eye anomalies.

The POMGNT2 gene is associated with MDDGA8, and Next-Generation Sequencing (NGS) genetic testing is used to identify mutations or variations in this gene. The cost of the POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 Genetic Test is AED 4400.0.

The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card. The sample condition should be maintained appropriately to ensure accurate results. The report delivery time for this test is approximately 3 to 4 weeks.

The POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 Genetic Test falls under the category of neurological disorders. Therefore, it is recommended to consult a neurologist for this test.

The test is conducted in the Genetics department, and it is essential to provide the clinical history of the patient before undergoing the test. Additionally, a genetic counseling session is recommended to draw a pedigree chart of family members affected by MDDGA8.

NGS genetic testing helps healthcare professionals identify mutations in the POMGNT2 gene, which aids in diagnosing MDDGA8. This information is crucial for understanding the underlying cause of the disorder and providing appropriate medical management and genetic counseling for affected individuals and their families.

Test Name POMGNT2 Gene Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POMGNT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A8 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMGNT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A8
Test Details

The POMGNT2 gene is associated with a specific type of muscular dystrophy-dystroglycanopathy called congenital muscular dystrophy with brain and eye anomalies, type A8 (MDDGA8). This genetic disorder is characterized by muscle weakness and wasting, brain abnormalities, and eye anomalies.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the case of MDDGA8, NGS genetic testing can identify mutations or variations in the POMGNT2 gene that may be responsible for causing the disorder.

By performing NGS genetic testing, healthcare professionals can determine if a person has mutations in the POMGNT2 gene, which can help in diagnosing MDDGA8. This information is crucial for understanding the underlying cause of the disorder and can assist in providing appropriate medical management and genetic counseling for affected individuals and their families.

SKU: TEST-1760 Category:

Related products